
Healthcare & Pharmaceuticals · BSE
Asston Pharmaceuticals Limited, established in 2019, is a pharmaceutical company focused on exporting healthcare products worldwide. It offers a wide range of products, including tablets, capsules, sachets, and syrups. These cover various therapeutic areas such as pain relief, antibiotics, antifungals, vitamins, and more. The company manufactures medicines for its own sales as well as on a contract basis, mainly working directly with different marketers. It holds certifications from both Central and State FDA, along with NQA accreditation, and follows Quality Management System standards to maintain product quality. As of July 3, 2025, the company employs 46 permanent staff and 6 contractual workers across different departments.
Price Band
₹115 – ₹123
Issue Size
₹27.56 Cr
Lot Size
1000 shares
GMP
+21.1%
Est. Listing
₹149
at current GMP
Subscribed
186.59x
overall
Open
9 Jul 2025
Close
11 Jul 2025
Allotment
14 Jul 2025
Refund
15 Jul 2025
Demat Credit
16 Jul 2025
Listing
16 Jul 2025
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹123
Band: ₹115 – ₹123
Estimated Listing Price
₹149
Upper price + GMP
Lot Size
1000 shares
Min investment ₹1,23,000
Estimated Profit / Lot
₹26,000
1000 × ₹26
Grey Market Premium trend
+₹26
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹26 | 21.1% | ₹149 |
| 30 Oct 2026 | +₹26 | 21.1% | ₹149 |
| 29 Oct 2026 | +₹23 | 19.0% | ₹146 |
GMP is unofficial market data. Not a guarantee of listing performance.
Asston Pharmaceuticals Limited is bringing an initial public offering (IPO) in the Healthcare & Pharmaceuticals sector with an aggregate issue size of ₹27.56 Crores. The shares are offered at a price band of ₹115 to ₹123 per equity share on BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2025-07-11, the basis of allotment is scheduled to be finalized on 2025-07-14. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Maashitla Securities Private Limited) or the BSE allotment checking window.
The latest grey market premium for Asston Pharmaceuticals Limited IPO is ₹26, which indicates an expected listing price of ₹149.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.